Search

Search Constraints

You searched for: Author/Creator Bhatnagar, Bhavana

Search Results

1. A 2:1 randomized, open-label, phase II study of selinexor vs. physician's choice in older patients with relapsed or refractory acute myeloid leukemia. Issue 13 (10th November 2021)

2. A phase I study of lenalidomide plus chemotherapy with idarubicin and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high‐risk myelodysplastic syndrome. Issue 12 (19th September 2020)

3. Diagnostic utility of bronchoscopy in newly diagnosed acute leukemia patients. Issue 1 (2nd November 2021)

6. Midostaurin, bortezomib and MEC in relapsed/refractory acute myeloid leukemia. Issue 9 (1st September 2016)

7. Outcomes of the cyclophosphamide, vincristine, prednisone (CVP) +/− rituximab (R-CVP) regimen in older patients with newly diagnosed Ph- acute lymphoblastic leukemia. (February 2020)

8. Persistence of DNMT3A R882 mutations during remission does not adversely affect outcomes of patients with acute myeloid leukaemia. (1st August 2016)

9. Phase I study of AR-42 and decitabine in acute myeloid leukemia. Issue 6 (11th May 2020)

10. Posttraumatic stress disorder symptoms in patients with acute myeloid leukemia. Issue 14 (25th March 2021)